CORSETTI, VERONICA
CORSETTI, VERONICA
FARMACOLOGIA TRASLAZIONALE - IFT
N-terminal tau truncation in the pathogenesis of Alzheimer's disease (AD): Developing a novel diagnostic and therapeutic approach
2020 Amadoro, G; Latina, V; Corsetti, V; Calissano, P
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models
2020 Corsetti, Veronica; Borreca, Antonella; Latina, Valentina; Giacovazzo, Giacomo; Pignataro, Annabella; Krashia, Paraskevi; Natale, Francesca; Cocco, Sara; Rinaudo, Marco; Malerba, Francesca; Florio, Rita; Ciarapica, Roberta; Coccurello, Roberto; D'Amelio, Marcello; Ammassari-Teule, Martine; Grassi, Claudio; Calissano, Pietro; Amadoro, Giuseppina
Dynamic structural determinants underlie the neurotoxicity of the N-terminal tau 26-44 peptide in Alzheimer's disease and other human tauopathies
2019 Perini G.; Ciasca G.; Minelli E.; Papi M.; Palmieri V.; Maulucci G.; Nardini M.; Latina V.; Corsetti V.; Florenzano F.; Calissano P.; De Spirito M.; Amadoro G.
AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy. Borreca A, Latina V, Corsetti V, Middei S, Piccinin S, Della Valle F, Bussani R, Ammassari-Teule M, Nisticò R, Calissano P, Amadoro G.
2018 Borreca, A; Latina, V; Corsetti, V; Middei, S; Piccinin, S; Della Valle, F; Bussani, R; Ammassariteule, M; Nisticò, R; Calissano, P; Amadoro, G
NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's Disease.
2015 Corsetti V; Florenzano F; Atlante A; Bobba A; Ciotti MT; Natale F; Della Valle F; Borreca A; Manca A; Meli G; Ferraina C; Feligioni M; D'Aguanno S; Bussani R; AmmassariTeule M; Nicolin V; Calissano P; Amadoro G.
Morphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: the pink-parkin pathway
2014 Amadoro, G; Corsetti, V; Florenzano, F; Atlante, A; Bobba, A; Nicolin, V; Nori, Sl; Calissano, P
Does the term 'trophic' actually mean anti-amyloidogenic? The case of NGF
2010 Calissano, P; Amadoro, G; Matrone, C; Ciafrè, S; Marolda, R; Corsetti, V; Ciotti, Mt; Mercanti, D; Di Luzio, A; Severini, C; Provenzano, C; Canu, N
Spontaneous aggregation and altered intracellular distribution of endogenous alpha-synuclein during neuronal apoptosis.
2008 Gentile, A; Amadoro, G; Corsetti, V; Ciotti, Mt; Serafino, A; Calissano, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
N-terminal tau truncation in the pathogenesis of Alzheimer's disease (AD): Developing a novel diagnostic and therapeutic approach | 1-gen-2020 | Amadoro, G; Latina, V; Corsetti, V; Calissano, P | |
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models | 1-gen-2020 | Corsetti, Veronica; Borreca, Antonella; Latina, Valentina; Giacovazzo, Giacomo; Pignataro, Annabella; Krashia, Paraskevi; Natale, Francesca; Cocco, Sara; Rinaudo, Marco; Malerba, Francesca; Florio, Rita; Ciarapica, Roberta; Coccurello, Roberto; D'Amelio, Marcello; Ammassari-Teule, Martine; Grassi, Claudio; Calissano, Pietro; Amadoro, Giuseppina | |
Dynamic structural determinants underlie the neurotoxicity of the N-terminal tau 26-44 peptide in Alzheimer's disease and other human tauopathies | 1-gen-2019 | Perini G.; Ciasca G.; Minelli E.; Papi M.; Palmieri V.; Maulucci G.; Nardini M.; Latina V.; Corsetti V.; Florenzano F.; Calissano P.; De Spirito M.; Amadoro G. | |
AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy. Borreca A, Latina V, Corsetti V, Middei S, Piccinin S, Della Valle F, Bussani R, Ammassari-Teule M, Nisticò R, Calissano P, Amadoro G. | 1-gen-2018 | Borreca, A; Latina, V; Corsetti, V; Middei, S; Piccinin, S; Della Valle, F; Bussani, R; Ammassariteule, M; Nisticò, R; Calissano, P; Amadoro, G | |
NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's Disease. | 1-gen-2015 | Corsetti V; Florenzano F; Atlante A; Bobba A; Ciotti MT; Natale F; Della Valle F; Borreca A; Manca A; Meli G; Ferraina C; Feligioni M; D'Aguanno S; Bussani R; AmmassariTeule M; Nicolin V; Calissano P; Amadoro G. | |
Morphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: the pink-parkin pathway | 1-gen-2014 | Amadoro, G; Corsetti, V; Florenzano, F; Atlante, A; Bobba, A; Nicolin, V; Nori, Sl; Calissano, P | |
Does the term 'trophic' actually mean anti-amyloidogenic? The case of NGF | 1-gen-2010 | Calissano, P; Amadoro, G; Matrone, C; Ciafrè, S; Marolda, R; Corsetti, V; Ciotti, Mt; Mercanti, D; Di Luzio, A; Severini, C; Provenzano, C; Canu, N | |
Spontaneous aggregation and altered intracellular distribution of endogenous alpha-synuclein during neuronal apoptosis. | 1-gen-2008 | Gentile, A; Amadoro, G; Corsetti, V; Ciotti, Mt; Serafino, A; Calissano, P |